213 related articles for article (PubMed ID: 22350412)
1. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.
Pan Y; Zhang Q; Tian L; Wang X; Fan X; Zhang H; Claret FX; Yang H
Cancer Res; 2012 Apr; 72(7):1890-900. PubMed ID: 22350412
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
[TBL] [Abstract][Full Text] [Related]
3. Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27.
Gao L; Huang S; Ren W; Zhao L; Li J; Zhi K; Zhang Y; Qi H; Huang C
Med Oncol; 2012 Dec; 29(4):2499-504. PubMed ID: 22311264
[TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
5. Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma.
Pan Y; Wang M; Bu X; Zuo Y; Wang S; Wang D; Liu Q; Su B; Xu T; Wang C; Claret FX; Yang H
BMC Cancer; 2013 Jul; 13():323. PubMed ID: 23815987
[TBL] [Abstract][Full Text] [Related]
6. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
[TBL] [Abstract][Full Text] [Related]
7. Targeting Jab1/CSN5 in nasopharyngeal carcinoma.
Pan Y; Claret FX
Cancer Lett; 2012 Dec; 326(2):155-60. PubMed ID: 22867945
[TBL] [Abstract][Full Text] [Related]
8. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
[TBL] [Abstract][Full Text] [Related]
9. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
[TBL] [Abstract][Full Text] [Related]
11. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.
Wang Y; Wang Y; Cheng C; Ji Y; Zhao Y; Zou L; Shen A
J Cancer Res Clin Oncol; 2009 Jul; 135(7):951-9. PubMed ID: 19139918
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors.
Lee WS; Park ES; Kim DH; Kim TH; Lee HH; Chung SH
Eur J Gynaecol Oncol; 2012; 33(4):358-62. PubMed ID: 23091890
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma.
Chen L; Yuan D; Wang GL; Wang Y; Wu YY; Zhu J
J Korean Med Sci; 2010 Oct; 25(10):1438-42. PubMed ID: 20890423
[TBL] [Abstract][Full Text] [Related]
14. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.
Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A
Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
[TBL] [Abstract][Full Text] [Related]
16. JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.
Wang Y; Yu YN; Song S; Li TJ; Xiang JY; Zhang H; Lu MD; Ji F; Hu LQ
J Cancer Res Clin Oncol; 2014 Jun; 140(6):969-78. PubMed ID: 24671224
[TBL] [Abstract][Full Text] [Related]
17. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
Qin J; Wang Z; Wang Y; Ma L; Ni Q; Ke J
Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
[TBL] [Abstract][Full Text] [Related]
18. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
Kouvaraki MA; Korapati AL; Rassidakis GZ; Tian L; Zhang Q; Chiao P; Ho L; Evans DB; Claret FX
Cancer Res; 2006 Sep; 66(17):8581-9. PubMed ID: 16951171
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
Guo H; Jing L; Cheng Y; Atsaves V; Lv Y; Wu T; Su R; Zhang Y; Zhang R; Liu W; Rassidakis GZ; Wei Y; Nan K; Claret FX
Hepatology; 2016 Mar; 63(3):898-913. PubMed ID: 26606000
[TBL] [Abstract][Full Text] [Related]
20. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
Wang F; Wang Y; Yu X; Yang D; Wang Z; Lu C; Yuan Z; Xiao M; Shen A
J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]